Global Fund Awards $34.2 Million Grant to Russia for HIV/AIDS, Tuberculosis Treatment, Care
July 2, 2004
The Global Fund to Fight AIDS, Tuberculosis and Malaria has awarded Russia a two-year, $34.2 million grant for the treatment and care of people living with HIV/AIDS and tuberculosis, the Los Angeles Times reports. HHS Secretary Tommy Thompson, who also serves as chair of the Global Fund Board, during a series of meetings in Moscow on Thursday announced the grant approval (Holley, Los Angeles Times, 7/2). The grant is the third Global Fund grant awarded to Russia (Oxley, Reuters, 7/1). The fund in 2003 awarded Russia an $88.7 million HIV/AIDS grant and a $10.8 million TB grant (HHS release, 7/1). Thompson and Russian Health Minister Mikhail Zurabov also announced that the countries have agreed in principle on an effort to reduce the cost of antiretroviral drugs from between $10,000 and $15,000 per patient per year to between $500 and $1,000 per patient per year. Neither Thompson nor Zurabov would discuss details of the plan, according to the Times (Los Angeles Times, 7/2). Zurabov said that the country will use only "patented and effective medicines," according to RIA Novosty (RIA Novosty, 7/1). "The decrease in price doesn't mean we'll be using lower quality medicines than in economically developed countries," Zurabov said, adding, "They will be the same set of drugs but at a lower price." Thompson said that the grant and the drug plan will help provide antiretroviral therapy for 5,000 people in the first year and up to 75,000 people by the fifth year (Reuters, 7/1).
Meetings, Other Plans
Generic Fixed-Dose Combination Antiretroviral Drug Triomune as Effective as Brand-Name Treatment, Study Says
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.